Improvement of Clopidogrel Hypo-Responsiveness by Cilostazol Addition to the Dual Antiplatelet Therapy in PCI Patients Carrying CYP2C19 Gene Polymorphism

被引：0
|
作者：
Tanigawa, Takashi [1 ]
Nakata, Tomoyuki [1 ]
Ito, Masaaki [1 ]
Nishikawa, Masakatsu [1 ]
机构：
[1] Mie Univ Hosp, Tsu, Mie, Japan
来源：
CIRCULATION | 2010年 / 122卷 / 21期
关键词：
Antiplatelet drugs; Platelet receptor blockers; Intervention;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A14257
引用
收藏
页数：2
相关论文
共 50 条
  • [1] New determinant of clopidogrel hypo-responsiveness in patients with dual antiplatelet maintenance therapy
    Kim, M. H.
    Lee, D. H.
    Guo, L. Z.
    Jin, C. D.
    Park, M. K.
    Lee, S. J.
    EUROPEAN HEART JOURNAL, 2014, 35 : 350 - 350
  • [2] The impact of CYP2C19 gene polymorphism on the antiplatelet effect of clopidogrel and ticlopidine; the efficacy of ticlopidine on the non-responders of clopidogrel with CYP2C19 gene polymorphism
    Ishiguro, H.
    Asai, T.
    Umemoto, N.
    Sumida, A.
    Shimizu, K.
    Murohara, T.
    Maeda, A.
    Ando, H.
    Fujimura, A.
    EUROPEAN HEART JOURNAL, 2010, 31 : 968 - 968
  • [3] Bedside testing of CYP2C19 gene for treatment of patients with PCI with antiplatelet therapy
    Al-Rubaish, Abdullah M.
    Al-Muhanna, Fahad A.
    Alshehri, Abdullah M.
    Al-Mansori, Mohammed A.
    Alali, Rudaynah A.
    Khalil, Rania M.
    Al Faraidy, Khalid A.
    Cyrus, Cyril
    Sulieman, Mohammed M.
    Vatte, Chittibabu
    Claassens, Daniel M. F.
    ten Berg, Jurrien M.
    Asselbergs, Folkert W.
    Al-Ali, Amein K.
    BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)
  • [4] CYP2C19 polymorphism and antiplatelet effects of clopidogrel in Chinese stroke patients
    Yang Jie
    Zhao Hong-Dong
    Tan Jie
    Ding Yun-Long
    Zou Jian-Jun
    PHARMAZIE, 2013, 68 (03): : 183 - 186
  • [5] Bedside testing of CYP2C19 gene for treatment of patients with PCI with antiplatelet therapy
    Abdullah M. Al-Rubaish
    Fahad A. Al-Muhanna
    Abdullah M. Alshehri
    Mohammed A. Al-Mansori
    Rudaynah A. Alali
    Rania M. Khalil
    Khalid A. Al Faraidy
    Cyril Cyrus
    Mohammed M. Sulieman
    Chittibabu Vatte
    Daniel M. F. Claassens
    Jurriën M. ten Berg
    Folkert W. Asselbergs
    Amein K. Al-Ali
    BMC Cardiovascular Disorders, 20
  • [6] CYP2C19 gene polymorphism and platelet responsiveness to clopidogrel in Korean patients with ischemic stroke
    Lee, H. C.
    Lee, B. C.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 880 - 880
  • [7] Correlation between clopidogrel low response and CYP2C19 gene polymorphism in CAD patients after PCI
    Yang, Shengli
    Sun, Yaqin
    Yang, Yong
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C136 - C136
  • [8] Antiplatelet response to clopidogrel is associated with a haplotype in CYP2C19 gene in Pakistani patients
    Ahmed, Sagheer
    Gul, Saima
    Siraj, Sami
    Hussain, Abrar
    Sheikh, Fahad Sultan
    Shah, Saeed Ullah
    Janjua, Kholood
    Khan, Hizbullah
    Hamdard, Mohammad Hamid
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [9] Antiplatelet response to clopidogrel is associated with a haplotype in CYP2C19 gene in Pakistani patients
    Sagheer Ahmed
    Saima Gul
    Sami Siraj
    Abrar Hussain
    Fahad Sultan Sheikh
    Saeed Ullah Shah
    Kholood Janjua
    Hizbullah Khan
    Mohammad Hamid Hamdard
    Scientific Reports, 12
  • [10] The effect of CYP2C19 gene polymorphism on clinical outcomes in patients with CAD receiving antiplatelet therapy
    Liu, W.
    Xi, Z. W.
    Zhou, Y. J.
    EUROPEAN HEART JOURNAL, 2017, 38 : 837 - 837
12345